Cash flows from operating activities: [Abstract] |
Net Loss |
Adjustments to reconcile net loss to net cash used in operating activities: [Abstract] |
Stock compensation expense |
884.17K |
Stock issued under stock purchase plan |
Fair value adjustment of common stock warrants EITF 07-05 (Topic 815) |
Depreciation and amortization - continuing operations |
2.13M |
Depreciation and amortization - discontinued operations |
Loss on disposal of property and equipment - discontinuing operations |
Loss on disposal of property and equipment - continuing operations |
Change in value of unconsolidated affiliate |
Changes in Continuing operating assets and liabilities: [Abstract] |
Prepaid expenses and other assets |
Accounts payable |
-1.78M |
Accrued expenses and other current liabilities |
500.88K |
Accounts receivables and Other receivables |
Provision for doubtful accounts and sales returns allowances |
Inventories, net |
Prepaid expenses and other current assets |
Accounts payable |
Accrued expenses and other current liabilities |
Accrued product warranty |
Deferred revenue |
Net cash used in operating activities |
Cash flows from investing activities: [Abstract] |
Acquisition of property and equipment - continuing operations |
-36.73K |
Notes Receivable for asset disposition |
Net cash provided by investing activities: |
Cash flows from financing activities: [Abstract] |
Net cash used in financing activities |
Effect of exchange rates on cash and cash equivalents |
Net decrease in cash and cash equivalents |
Cash and cash equivalents at beginning of period |
Cash and cash equivalents at end of period |
Supplemental disclosure of non-cash activities: |
Transfer of demo lab equipment between inventory (USA) and fixed assets (France) |